Theravance Biopharma, Inc. (TBPH)
13.57
-0.01
(-0.07%)
USD |
NASDAQ |
Mar 06, 16:00
13.56
-0.01
(-0.07%)
After-Hours: 20:00
Theravance Biopharma Cash from Investing (Quarterly) : -100.25M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Integer Holdings Corp. | -35.47M |
| QuidelOrtho Corp. | -49.60M |
| Corcept Therapeutics, Inc. | -11.84M |
| Nektar Therapeutics | -94.87M |
| Innoviva, Inc. | 23.64M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.508M |
| Cash from Financing (Quarterly) | -0.40M |
| Free Cash Flow | 243.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1254 |
| Free Cash Flow to Equity (Quarterly) | -4.646M |
| Free Cash Flow to Firm (Quarterly) | -7.225M |
| Free Cash Flow Yield | 35.59% |